Provenge minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP Images
Generic Name: sipuleucel-T
This medication has been identified as Provenge minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP. It is supplied by Dendreon Pharmaceuticals LLC.
Provenge is used in the treatment of Prostate Cancer and belongs to the drug class therapeutic vaccines. FDA has not classified the drug for risk during pregnancy. Provenge minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Provenge
- Generic Name
- sipuleucel-T
- Strength
- minimum of 50 million autologous CD54 + cells activated with PAP-GM-CSF in Lactated Ringer's Injection, USP
- Availability
- Prescription only
- Drug Class
- Therapeutic vaccines
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dendreon Pharmaceuticals LLC
- National Drug Code (NDC)
- 30237-8900
More about Provenge (sipuleucel-T)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: therapeutic vaccines
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
